Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

go back to reference Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D (2013) Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med 39:2135–2143PubMed Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D (2013) Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med 39:2135–2143PubMed

go back to reference Russell L, Haase N, Perner A (2018) Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis. Blood Coagul Fibrinolysis 29:683–688PubMed Russell L, Haase N, Perner A (2018) Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis. Blood Coagul Fibrinolysis 29:683–688PubMed

go back to reference Russell L, Holst LB, Kjeldsen L, Stensballe J, Perner A (2017) Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies. Ann Intensive Care 7:119PubMedPubMedCentral Russell L, Holst LB, Kjeldsen L, Stensballe J, Perner A (2017) Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies. Ann Intensive Care 7:119PubMedPubMedCentral

go back to reference Pham HP, Shaz BH (2013) Update on massive transfusion. Br J Anaesth 111(Suppl 1):i71-82PubMed Pham HP, Shaz BH (2013) Update on massive transfusion. Br J Anaesth 111(Suppl 1):i71-82PubMed

go back to reference de Bruin S, Scheeren TWL, Bakker J, van Bruggen R, Vlaar APJ, Cardiovascular Dynamics S, Transfusion Guideline Task Force of the E (2019) Transfusion practice in the non-bleeding critically ill: an international online survey-the TRACE survey. Crit Care 23:309PubMedPubMedCentral de Bruin S, Scheeren TWL, Bakker J, van Bruggen R, Vlaar APJ, Cardiovascular Dynamics S, Transfusion Guideline Task Force of the E (2019) Transfusion practice in the non-bleeding critically ill: an international online survey-the TRACE survey. Crit Care 23:309PubMedPubMedCentral

go back to reference Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, Aries P, Duranteau J, Juffermans NP, Meier J, Murphy GJ, Abbasciano R, Muller M, Shah A, Perner A, Rygaard S, Walsh TS, Guyatt G, Dionne JC, Cecconi M (2020) Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. https://doi.org/10.1007/s00134-019-05884-8CrossRefPubMedPubMedCentral Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, Aries P, Duranteau J, Juffermans NP, Meier J, Murphy GJ, Abbasciano R, Muller M, Shah A, Perner A, Rygaard S, Walsh TS, Guyatt G, Dionne JC, Cecconi M (2020) Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. https://​doi.​org/​10.​1007/​s00134-019-05884-8CrossRefPubMedPubMedCentral

go back to reference Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926PubMedPubMedCentral Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926PubMedPubMedCentral

go back to reference Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395–400PubMed Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395–400PubMed

go back to reference Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan: a web and mobile app for systematic reviews. Syst Rev 5:210PubMedPubMedCentral Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan: a web and mobile app for systematic reviews. Syst Rev 5:210PubMedPubMedCentral

go back to reference Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, New Jersey Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, New Jersey

go back to reference Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa City Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa City

go back to reference Manager R (2014) Book version 5.4. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen Manager R (2014) Book version 5.4. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen

go back to reference Cornell JEMC, Localio R, Stack CB, Meibohm AR, Guallar E, Goodman SN (2014) Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med 160:267–270PubMed Cornell JEMC, Localio R, Stack CB, Meibohm AR, Guallar E, Goodman SN (2014) Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med 160:267–270PubMed

go back to reference Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schunemann HJ (2011) GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol 64:407–415PubMed Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schunemann HJ (2011) GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol 64:407–415PubMed

go back to reference Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Schunemann HJ, Group GW (2011) GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol 64:1294–1302PubMed Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Schunemann HJ, Group GW (2011) GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol 64:1294–1302PubMed

go back to reference Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Schunemann HJ, Group GW (2011) GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol 64:1303–1310PubMed Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Schunemann HJ, Group GW (2011) GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol 64:1303–1310PubMed

go back to reference Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schunemann HJ (2011) GRADE guidelines 6. Rating the quality of evidence–imprecision. J Clin Epidemiol 64:1283–1293PubMed Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schunemann HJ (2011) GRADE guidelines 6. Rating the quality of evidence–imprecision. J Clin Epidemiol 64:1283–1293PubMed

go back to reference Jaeschke R, Guyatt GH, Dellinger P, Schunemann H, Levy MM, Kunz R, Norris S, Bion J (2008) Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. Br Med J 337:a744 Jaeschke R, Guyatt GH, Dellinger P, Schunemann H, Levy MM, Kunz R, Norris S, Bion J (2008) Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. Br Med J 337:a744

go back to reference McQuilten ZK, Crighton G, Brunskill S, Morison JK, Richter TH, Waters N, Murphy MF, Wood EM (2018) Optimal dose, timing and ratio of blood products in massive transfusion: results from a systematic review. Transfus Med Rev 32:6–15PubMed McQuilten ZK, Crighton G, Brunskill S, Morison JK, Richter TH, Waters N, Murphy MF, Wood EM (2018) Optimal dose, timing and ratio of blood products in massive transfusion: results from a systematic review. Transfus Med Rev 32:6–15PubMed

go back to reference Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G, Group PS (2015) Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313:471–482PubMedPubMedCentral Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G, Group PS (2015) Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313:471–482PubMedPubMedCentral

go back to reference Nascimento B, Callum J, Tien H, Rubenfeld G, Pinto R, Lin Y, Rizoli S (2013) Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 185:E583-589PubMedPubMedCentral Nascimento B, Callum J, Tien H, Rubenfeld G, Pinto R, Lin Y, Rizoli S (2013) Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 185:E583-589PubMedPubMedCentral

go back to reference Etchill EW, Myers SP, McDaniel LM, Rosengart MR, Raval JS, Triulzi DJ, Peitzman AB, Sperry JL, Neal MD (2017) Should all massively transfused patients be treated equally? An analysis of massive transfusion ratios in the nontrauma setting. Crit Care Med 45:1311–1316PubMed Etchill EW, Myers SP, McDaniel LM, Rosengart MR, Raval JS, Triulzi DJ, Peitzman AB, Sperry JL, Neal MD (2017) Should all massively transfused patients be treated equally? An analysis of massive transfusion ratios in the nontrauma setting. Crit Care Med 45:1311–1316PubMed

go back to reference Mesar T, Larentzakis A, Dzik W, Chang Y, Velmahos G, Yeh DD (2017) Association between ratio of fresh frozen plasma to red blood cells during massive transfusion and survival among patients without traumatic injury. JAMA Surg 152:574–580PubMedPubMedCentral Mesar T, Larentzakis A, Dzik W, Chang Y, Velmahos G, Yeh DD (2017) Association between ratio of fresh frozen plasma to red blood cells during massive transfusion and survival among patients without traumatic injury. JAMA Surg 152:574–580PubMedPubMedCentral

go back to reference Sinha R, Roxby D, Bersten A (2013) Experience with a massive transfusion protocol in the management of massive haemorrhage. Transfus Med 23:108–113PubMed Sinha R, Roxby D, Bersten A (2013) Experience with a massive transfusion protocol in the management of massive haemorrhage. Transfus Med 23:108–113PubMed

go back to reference Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, Stowell CP, Sloan SR (2017) Massive transfusion in cardiac surgery: the impact of blood component ratios on clinical outcomes and survival. Anesth Analg 124:1777PubMedPubMedCentral Delaney M, Stark PC, Suh M, Triulzi DJ, Hess JR, Steiner ME, Stowell CP, Sloan SR (2017) Massive transfusion in cardiac surgery: the impact of blood component ratios on clinical outcomes and survival. Anesth Analg 124:1777PubMedPubMedCentral

go back to reference Dutta EH, Poole AT, Behnia F, Dunn HE, Clark SM, Pacheco LD, Saade GR, Hankins GDV (2017) Hemostatic resuscitation in peripartum hysterectomy pre- and postmassive transfusion protocol initiation. Am J Perinatol 34:861–866PubMed Dutta EH, Poole AT, Behnia F, Dunn HE, Clark SM, Pacheco LD, Saade GR, Hankins GDV (2017) Hemostatic resuscitation in peripartum hysterectomy pre- and postmassive transfusion protocol initiation. Am J Perinatol 34:861–866PubMed

go back to reference Weiniger CF, Yakirevich-Amir N, Sela HY, Gural A, Ioscovich A, Einav S (2018) Retrospective study to investigate fresh frozen plasma and packed cell ratios when administered for women with postpartum hemorrhage, before and after introduction of a massive transfusion protocol. Int J Obstet Anesth 36:34–41PubMed Weiniger CF, Yakirevich-Amir N, Sela HY, Gural A, Ioscovich A, Einav S (2018) Retrospective study to investigate fresh frozen plasma and packed cell ratios when administered for women with postpartum hemorrhage, before and after introduction of a massive transfusion protocol. Int J Obstet Anesth 36:34–41PubMed

go back to reference Consunji R, Elseed A, El-Menyar A, Sathian B, Rizoli S, Al-Thani H, Peralta R (2020) The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta-analysis. Blood Transfus 18:434–445PubMedPubMedCentral Consunji R, Elseed A, El-Menyar A, Sathian B, Rizoli S, Al-Thani H, Peralta R (2020) The effect of massive transfusion protocol implementation on the survival of trauma patients: a systematic review and meta-analysis. Blood Transfus 18:434–445PubMedPubMedCentral

go back to reference Bohonek M, Kutac D, Landova L, Koranova M, Sladkova E, Staskova E, Voldrich M, Tyll T (2019) The use of cryopreserved platelets in the treatment of polytraumatic patients and patients with massive bleeding. Transfusion 59:1474–1478PubMed Bohonek M, Kutac D, Landova L, Koranova M, Sladkova E, Staskova E, Voldrich M, Tyll T (2019) The use of cryopreserved platelets in the treatment of polytraumatic patients and patients with massive bleeding. Transfusion 59:1474–1478PubMed

go back to reference Strandenes G, Sivertsen J, Bjerkvig CK, Fosse TK, Cap AP, Del Junco DJ, Kristoffersen EK, Haaverstad R, Kvalheim V, Braathen H, Lunde THF, Hervig T, Hufthammer KO, Spinella PC, Apelseth TO (2020) A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery. Anesthesiology 133:1173–1183PubMed Strandenes G, Sivertsen J, Bjerkvig CK, Fosse TK, Cap AP, Del Junco DJ, Kristoffersen EK, Haaverstad R, Kvalheim V, Braathen H, Lunde THF, Hervig T, Hufthammer KO, Spinella PC, Apelseth TO (2020) A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery. Anesthesiology 133:1173–1183PubMed

go back to reference Arnekian V, Camous J, Fattal S, Rezaiguia-Delclaux S, Nottin R, Stephan F (2012) Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 15:382–389PubMedPubMedCentral Arnekian V, Camous J, Fattal S, Rezaiguia-Delclaux S, Nottin R, Stephan F (2012) Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 15:382–389PubMedPubMedCentral

go back to reference Biancari F, Ruggieri VG, Perrotti A, Gherli R, Demal T, Franzese I, Dalen M, Santarpino G, Rubino AS, Maselli D, Salsano A, Nicolini F, Saccocci M, Gatti G, Rosato S, D’Errigo P, Kinnunen EM, De Feo M, Tauriainen T, Onorati F, Mariscalco G (2019) Comparative analysis of prothrombin complex concentrate and fresh frozen plasma in coronary surgery. Heart Lung Circ 28:1881–1887PubMed Biancari F, Ruggieri VG, Perrotti A, Gherli R, Demal T, Franzese I, Dalen M, Santarpino G, Rubino AS, Maselli D, Salsano A, Nicolini F, Saccocci M, Gatti G, Rosato S, D’Errigo P, Kinnunen EM, De Feo M, Tauriainen T, Onorati F, Mariscalco G (2019) Comparative analysis of prothrombin complex concentrate and fresh frozen plasma in coronary surgery. Heart Lung Circ 28:1881–1887PubMed

go back to reference Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C (2016) Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. Crit Care 20:5PubMedPubMedCentral Cappabianca G, Mariscalco G, Biancari F, Maselli D, Papesso F, Cottini M, Crosta S, Banescu S, Ahmed AB, Beghi C (2016) Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery. Crit Care 20:5PubMedPubMedCentral

go back to reference Fitzgerald J, Lenihan M, Callum J, McCluskey SA, Srinivas C, van Rensburg A, Karkouti K (2018) Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma. Br J Anaesth 120:928–934PubMed Fitzgerald J, Lenihan M, Callum J, McCluskey SA, Srinivas C, van Rensburg A, Karkouti K (2018) Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma. Br J Anaesth 120:928–934PubMed

go back to reference Ortmann E, Besser MW, Sharples LD, Gerrard C, Berman M, Jenkins DP, Klein AA (2015) An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 121:26–33PubMed Ortmann E, Besser MW, Sharples LD, Gerrard C, Berman M, Jenkins DP, Klein AA (2015) An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 121:26–33PubMed

go back to reference Akbari E, Safari S, Hatamabadi H (2018) The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: a quasi-experimental study. Am J Emerg Med 36:1947–1950PubMed Akbari E, Safari S, Hatamabadi H (2018) The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: a quasi-experimental study. Am J Emerg Med 36:1947–1950PubMed

go back to reference Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, Hodge R, Hopkins V, Deary A, Ray J, Moss P, Reed MJ, Kellett S, Davenport R, Stanworth S (2018) Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care 22:164PubMedPubMedCentral Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, Hodge R, Hopkins V, Deary A, Ray J, Moss P, Reed MJ, Kellett S, Davenport R, Stanworth S (2018) Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care 22:164PubMedPubMedCentral

go back to reference Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, Gruber G, Schmid S, Friesenecker B, Lorenz IH, Ströhle M, Rastner V, Trübsbach S, Raab H, Treml B, Wally D, Treichl B, Mayr A, Kranewitter C, Oswald E (2017) Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 4:e258–e271PubMed Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, Gruber G, Schmid S, Friesenecker B, Lorenz IH, Ströhle M, Rastner V, Trübsbach S, Raab H, Treml B, Wally D, Treichl B, Mayr A, Kranewitter C, Oswald E (2017) Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 4:e258–e271PubMed

go back to reference Nascimento B, Callum J, Tien H, Peng H, Rizoli S, Karanicolas P, Alam A, Xiong W, Selby R, Garzon AM, Colavecchia C, Howald R, Nathens A, Beckett A (2016) Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth 117:775–782PubMed Nascimento B, Callum J, Tien H, Peng H, Rizoli S, Karanicolas P, Alam A, Xiong W, Selby R, Garzon AM, Colavecchia C, Howald R, Nathens A, Beckett A (2016) Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth 117:775–782PubMed

go back to reference Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A (2012) Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 43:26–32PubMed Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A (2012) Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 43:26–32PubMed

go back to reference Inaba K, Karamanos E, Lustenberger T, Schöchl H, Shulman I, Nelson J, Rhee P, Talving P, Lam L, Demetriades D (2013) Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg 216:290–297PubMed Inaba K, Karamanos E, Lustenberger T, Schöchl H, Shulman I, Nelson J, Rhee P, Talving P, Lam L, Demetriades D (2013) Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg 216:290–297PubMed

go back to reference Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen MJ, Johansson PI, Røislien J, Eken T, Næss PA, Gaarder C (2014) Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care 18:1–8 Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen MJ, Johansson PI, Røislien J, Eken T, Næss PA, Gaarder C (2014) Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care 18:1–8

go back to reference Wirtz MR, Schalkers DV, Goslings JC, Juffermans NP (2020) The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients. Transfusion 60:1873–1882PubMedPubMedCentral Wirtz MR, Schalkers DV, Goslings JC, Juffermans NP (2020) The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients. Transfusion 60:1873–1882PubMedPubMedCentral

go back to reference Moller A, Nielsen HB, Wetterslev J, Pedersen OB, Hellemann D, Winkel P, Marcussen KV, Ramsing BGU, Mortensen A, Jakobsen JC, Shahidi S (2019) Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial. Blood 133:2639–2650PubMed Moller A, Nielsen HB, Wetterslev J, Pedersen OB, Hellemann D, Winkel P, Marcussen KV, Ramsing BGU, Mortensen A, Jakobsen JC, Shahidi S (2019) Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial. Blood 133:2639–2650PubMed

go back to reference Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, Akerboom BM, van Alphen M, Bloemenkamp KW, Boers KE, Bremer HA, Kwee A, van Loon AJ, Metz GC, Papatsonis DN, van der Post JA, Porath MM, Rijnders RJ, Roumen FJ, Scheepers HC, Schippers DH, Schuitemaker NW, Stigter RH, Woiski MD, Mol BW, van Rhenen DJ, Duvekot JJ (2014) Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 121:1005–1014PubMed Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de Groot CA, Akerboom BM, van Alphen M, Bloemenkamp KW, Boers KE, Bremer HA, Kwee A, van Loon AJ, Metz GC, Papatsonis DN, van der Post JA, Porath MM, Rijnders RJ, Roumen FJ, Scheepers HC, Schippers DH, Schuitemaker NW, Stigter RH, Woiski MD, Mol BW, van Rhenen DJ, Duvekot JJ (2014) Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 121:1005–1014PubMed

go back to reference Green L, Connolly C, Cooper TK, Cho G, Allard S (2015) Book blood transfusions in obstetrics. Royal College of Obstetricians and Gynaecologists, London Green L, Connolly C, Cooper TK, Cho G, Allard S (2015) Book blood transfusions in obstetrics. Royal College of Obstetricians and Gynaecologists, London

go back to reference Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, Riris S, Thompson AJ (2017) Prevention and management of postpartum haemorrhage: green-top guideline no. 52. Royal College of Obstetricians and Gynaecologists, London, pp e106–e149 Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, Riris S, Thompson AJ (2017) Prevention and management of postpartum haemorrhage: green-top guideline no. 52. Royal College of Obstetricians and Gynaecologists, London, pp e106–e149

go back to reference Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santalo M, Muniz E, Guarner C (2013) Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368:11–21PubMed Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, Guarner-Argente C, Santalo M, Muniz E, Guarner C (2013) Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368:11–21PubMed

go back to reference Blair S, Janvrin SB, Mccollum CN, Greenhalgh RM (1986) Effect of early blood transfusion on gastrointestinal hemorrhage. Br J Surg 73:783–785PubMed Blair S, Janvrin SB, Mccollum CN, Greenhalgh RM (1986) Effect of early blood transfusion on gastrointestinal hemorrhage. Br J Surg 73:783–785PubMed

go back to reference Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF (2015) Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 386:137–144PubMed Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF (2015) Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 386:137–144PubMed

go back to reference Villarejo F, Rizzolo M, Lopez E, Domeniconi G, Atro G, Apezteguia C (1999) Acute anemia in high digestive hemorrhage. Margins of secruity for their handling without transfusion of red gobules. Acta Gastroenterol Latinoam 29:261–270PubMed Villarejo F, Rizzolo M, Lopez E, Domeniconi G, Atro G, Apezteguia C (1999) Acute anemia in high digestive hemorrhage. Margins of secruity for their handling without transfusion of red gobules. Acta Gastroenterol Latinoam 29:261–270PubMed

go back to reference Engel-Haber E, Horev A, Chablani P, Bornstein NM, Jadhav A, Jovin TG, Reddy V, Hammer MD (2015) Aspirin response test role in platelet transfusion following intracerebral hemorrhage. Clin Neurol Neurosurg 137:12–14PubMed Engel-Haber E, Horev A, Chablani P, Bornstein NM, Jadhav A, Jovin TG, Reddy V, Hammer MD (2015) Aspirin response test role in platelet transfusion following intracerebral hemorrhage. Clin Neurol Neurosurg 137:12–14PubMed

go back to reference Baharoglu MI, Cordonnier C, Salman RA-S, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387:2605–2613PubMed Baharoglu MI, Cordonnier C, Salman RA-S, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387:2605–2613PubMed

go back to reference Kim DY, O’Leary M, Nguyen A, Kaji A, Bricker S, Neville A, Bongard F, Putnam B, Plurad D (2015) The effect of platelet and desmopressin administration on early radiographic progression of traumatic intracranial hemorrhage. J Neurotrauma 32:1815–1821PubMed Kim DY, O’Leary M, Nguyen A, Kaji A, Bricker S, Neville A, Bongard F, Putnam B, Plurad D (2015) The effect of platelet and desmopressin administration on early radiographic progression of traumatic intracranial hemorrhage. J Neurotrauma 32:1815–1821PubMed

go back to reference Lisman T, Weeterings C, de Groot PG (2005) Platelet aggregation: involvement of thrombin and fibrin (ogen). Front Biosci 10:2504–2517PubMed Lisman T, Weeterings C, de Groot PG (2005) Platelet aggregation: involvement of thrombin and fibrin (ogen). Front Biosci 10:2504–2517PubMed

go back to reference Bilecen S, de Groot JA, Kalkman CJ, Spanjersberg AJ, Brandon Bravo Bruinsma GJ, Moons KG, Nierich AP (2017) Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial. JAMA 317:738–747PubMed Bilecen S, de Groot JA, Kalkman CJ, Spanjersberg AJ, Brandon Bravo Bruinsma GJ, Moons KG, Nierich AP (2017) Effect of fibrinogen concentrate on intraoperative blood loss among patients with intraoperative bleeding during high-risk cardiac surgery: a randomized clinical trial. JAMA 317:738–747PubMed

go back to reference Esmaeelzadeh M, Amini S, Soltani G, Abbasi Tashnizi M, Azami M (2016) Exogenous fibrinogen pertains beneficial effects in managing post-cardiac surgery bleeding: a randomized clinical trial. J Cardio-Thorac Med 4:474–479 Esmaeelzadeh M, Amini S, Soltani G, Abbasi Tashnizi M, Azami M (2016) Exogenous fibrinogen pertains beneficial effects in managing post-cardiac surgery bleeding: a randomized clinical trial. J Cardio-Thorac Med 4:474–479

go back to reference Morrison GA, Koch J, Royds M, McGee D, Chalmers RTA, Anderson J, Nimmo AF (2019) Fibrinogen concentrate vs. fresh frozen plasma for the management of coagulopathy during thoraco-abdominal aortic aneurysm surgery: a pilot randomised controlled trial. Anaesthesia 74:180–189PubMed Morrison GA, Koch J, Royds M, McGee D, Chalmers RTA, Anderson J, Nimmo AF (2019) Fibrinogen concentrate vs. fresh frozen plasma for the management of coagulopathy during thoraco-abdominal aortic aneurysm surgery: a pilot randomised controlled trial. Anaesthesia 74:180–189PubMed

go back to reference Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sorensen B, Hagl C, Pichlmaier M (2013) Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 118:40–50PubMed Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sorensen B, Hagl C, Pichlmaier M (2013) Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 118:40–50PubMed

go back to reference Rahe-Meyer N, Levy JH, Mazer CD, Schramko A, Klein AA, Brat R, Okita Y, Ueda Y, Schmidt DS, Ranganath R, Gill R (2016) Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth 117:41–51PubMedPubMedCentral Rahe-Meyer N, Levy JH, Mazer CD, Schramko A, Klein AA, Brat R, Okita Y, Ueda Y, Schmidt DS, Ranganath R, Gill R (2016) Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. Br J Anaesth 117:41–51PubMedPubMedCentral

go back to reference Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A, Surgical Clinical Outcome RG (2015) Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 4:e002066PubMedPubMedCentral Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A, Surgical Clinical Outcome RG (2015) Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 4:e002066PubMedPubMedCentral

go back to reference Tanaka KA, Egan K, Szlam F, Ogawa S, Roback JD, Sreeram G, Guyton RA, Chen EP (2014) Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion 54:109–118PubMed Tanaka KA, Egan K, Szlam F, Ogawa S, Roback JD, Sreeram G, Guyton RA, Chen EP (2014) Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion 54:109–118PubMed

go back to reference Lance MD, Ninivaggi M, Schols SE, Feijge MA, Oehrl SK, Kuiper GJ, Nikiforou M, Marcus MA, Hamulyak K, van Pampus EC, ten Cate H, Heemskerk JW (2012) Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sang 103:25–34PubMed Lance MD, Ninivaggi M, Schols SE, Feijge MA, Oehrl SK, Kuiper GJ, Nikiforou M, Marcus MA, Hamulyak K, van Pampus EC, ten Cate H, Heemskerk JW (2012) Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial. Vox Sang 103:25–34PubMed

go back to reference Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussieres J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, Group FR (2019) Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2019.17312CrossRefPubMedPubMedCentral Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke HP, Carroll J, Grewal D, Brar S, Bussieres J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M, Karkouti K, Group FR (2019) Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. https://​doi.​org/​10.​1001/​jama.​2019.​17312CrossRefPubMedPubMedCentral

go back to reference Torres LN, Chung KK, Salgado CL, Dubick MA, Torres Filho IP (2017) Low-volume resuscitation with normal saline is associated with microvascular endothelial dysfunction after hemorrhage in rats, compared to colloids and balanced crystalloids. Crit Care 21:160PubMedPubMedCentral Torres LN, Chung KK, Salgado CL, Dubick MA, Torres Filho IP (2017) Low-volume resuscitation with normal saline is associated with microvascular endothelial dysfunction after hemorrhage in rats, compared to colloids and balanced crystalloids. Crit Care 21:160PubMedPubMedCentral

go back to reference Chang R, Holcomb JB, Johansson PI, Pati S, Schreiber MA, Wade CE (2018) Plasma resuscitation improved survival in a cecal ligation and puncture rat model of sepsis. Shock 49:53–61PubMedPubMedCentral Chang R, Holcomb JB, Johansson PI, Pati S, Schreiber MA, Wade CE (2018) Plasma resuscitation improved survival in a cecal ligation and puncture rat model of sepsis. Shock 49:53–61PubMedPubMedCentral

go back to reference Kumar M, Ahmad J, Maiwall R, Choudhury A, Bajpai M, Mitra LG, Saluja V, Mohan Agarwal P, Bihari C, Shasthry SM, Jindal A, Bhardwaj A, Kumar G, Sarin SK (2020) Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology 71:235–246PubMed Kumar M, Ahmad J, Maiwall R, Choudhury A, Bajpai M, Mitra LG, Saluja V, Mohan Agarwal P, Bihari C, Shasthry SM, Jindal A, Bhardwaj A, Kumar G, Sarin SK (2020) Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology 71:235–246PubMed

go back to reference Rout G, Shalimar GD, Mahapatra SJ, Kedia S, Garg PK, Nayak B (2020) Thromboelastography-guided blood product transfusion in cirrhosis patients with variceal bleeding: a randomized controlled trial. J Clin Gastroenterol 54:255–262PubMed Rout G, Shalimar GD, Mahapatra SJ, Kedia S, Garg PK, Nayak B (2020) Thromboelastography-guided blood product transfusion in cirrhosis patients with variceal bleeding: a randomized controlled trial. J Clin Gastroenterol 54:255–262PubMed

go back to reference Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane database of systematic reviews. John Wiley and Sons, Chichester, p CD009052 Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR (2011) Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane database of systematic reviews. John Wiley and Sons, Chichester, p CD009052

go back to reference Smart L, Mumtaz K, Scharpf D, Gray NO, Traetow D, Black S, Michaels AJ, Elkhammas E, Kirkpatrick R, Hanje AJ (2017) Rotational thromboelastometry or conventional coagulation tests in liver transplantation: comparing blood loss, transfusions, and cost. Ann Hepatol 16:916–923PubMed Smart L, Mumtaz K, Scharpf D, Gray NO, Traetow D, Black S, Michaels AJ, Elkhammas E, Kirkpatrick R, Hanje AJ (2017) Rotational thromboelastometry or conventional coagulation tests in liver transplantation: comparing blood loss, transfusions, and cost. Ann Hepatol 16:916–923PubMed

go back to reference Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, Burlew CC, Johnson JL, Pieracci FM, Jurkovich GJ, Banerjee A, Silliman CC, Sauaia A (2016) Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 263:1051–1059PubMed Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, Ghasabyan A, Wohlauer MV, Barnett CC, Bensard DD, Biffl WL, Burlew CC, Johnson JL, Pieracci FM, Jurkovich GJ, Banerjee A, Silliman CC, Sauaia A (2016) Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 263:1051–1059PubMed

go back to reference Meco M, Montisci A, Giustiniano E, Greco M, Pappalardo F, Mammana L, Panisi P, Roscitano C, Cirri S, Donatelli F, Albano G (2020) Viscoelastic blood tests use in adult cardiac surgery: meta-analysis, meta-regression, and trial sequential analysis. J Cardiothorac Vasc Anesth 34:119–127PubMed Meco M, Montisci A, Giustiniano E, Greco M, Pappalardo F, Mammana L, Panisi P, Roscitano C, Cirri S, Donatelli F, Albano G (2020) Viscoelastic blood tests use in adult cardiac surgery: meta-analysis, meta-regression, and trial sequential analysis. J Cardiothorac Vasc Anesth 34:119–127PubMed

go back to reference Serraino GF, Murphy GJ (2017) Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth 118:823–833PubMed Serraino GF, Murphy GJ (2017) Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth 118:823–833PubMed

go back to reference Buscher H, Zhang D, Nair P (2017) A pilot randomised controlled trial of a totational thromboelastometry-based algorithm to treat bleeding episodes in extracorporeal life support: the TEM protocol in ECLS study (TEMPEST). Crit Care Resusc 19:000–000 Buscher H, Zhang D, Nair P (2017) A pilot randomised controlled trial of a totational thromboelastometry-based algorithm to treat bleeding episodes in extracorporeal life support: the TEM protocol in ECLS study (TEMPEST). Crit Care Resusc 19:000–000

go back to reference Murphy GJ, Mumford AD, Rogers CA, Wordsworth S, Stokes EA, Verheyden V, Kumar T, Harris J, Clayton G, Ellis L, Plummer Z, Dott W, Serraino F, Wozniak M, Morris T, Nath M, Sterne JA, Angelini GD, Reeves BC (2017) Diagnostic amd therapeutic medical devices for safer blood management in cardiac surgery: systematic reviews, observational studies and randomised controlled trials. Program Grants Appl Res. https://doi.org/10.3310/pgfar05170CrossRef Murphy GJ, Mumford AD, Rogers CA, Wordsworth S, Stokes EA, Verheyden V, Kumar T, Harris J, Clayton G, Ellis L, Plummer Z, Dott W, Serraino F, Wozniak M, Morris T, Nath M, Sterne JA, Angelini GD, Reeves BC (2017) Diagnostic amd therapeutic medical devices for safer blood management in cardiac surgery: systematic reviews, observational studies and randomised controlled trials. Program Grants Appl Res. https://​doi.​org/​10.​3310/​pgfar05170CrossRef

go back to reference Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, Qureshi S, Lai FY, Kumar T, Richards T, Yao G, Estcourt L, Murphy GJ (2021) Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis. Br J Anaesth 126:149–156PubMed Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, Qureshi S, Lai FY, Kumar T, Richards T, Yao G, Estcourt L, Murphy GJ (2021) Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis. Br J Anaesth 126:149–156PubMed

go back to reference Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23–32PubMed Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23–32PubMed

go back to reference Collaborators CT (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723 Collaborators CT (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723

go back to reference Guerriero C, Cairns J, Perel P, Shakur H, Roberts I, Collaborators CT (2011) Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS ONE 6:e18987PubMedPubMedCentral Guerriero C, Cairns J, Perel P, Shakur H, Roberts I, Collaborators CT (2011) Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS ONE 6:e18987PubMedPubMedCentral

go back to reference Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K (2013) The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 11:307–314PubMed Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K (2013) The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 11:307–314PubMed

go back to reference Collaborators CT, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377:1096–1101 Collaborators CT, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377:1096–1101

go back to reference Napolitano LM (2017) Prehospital tranexamic acid: what is the current evidence? Trauma Surg Acute Care Open 2:e000056PubMedPubMedCentral Napolitano LM (2017) Prehospital tranexamic acid: what is the current evidence? Trauma Surg Acute Care Open 2:e000056PubMedPubMedCentral

go back to reference Lawati KA, Sharif S, Maqbali SA, Rimawi HA, Petrosoniak A, Belley-Cote EP, Sharma SV, Morgenstern J, Fernando SM, Owen JJ, Zeller M, Quinlan D, Alhazzani W, Rochwerg B (2020) Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials. Intensive Care Med. https://doi.org/10.1007/s00134-020-06279-wCrossRefPubMed Lawati KA, Sharif S, Maqbali SA, Rimawi HA, Petrosoniak A, Belley-Cote EP, Sharma SV, Morgenstern J, Fernando SM, Owen JJ, Zeller M, Quinlan D, Alhazzani W, Rochwerg B (2020) Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials. Intensive Care Med. https://​doi.​org/​10.​1007/​s00134-020-06279-wCrossRefPubMed

go back to reference Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA (2020) Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 324:961–974PubMedPubMedCentral Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA (2020) Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 324:961–974PubMedPubMedCentral

go back to reference Chandra B (1978) Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol 3:502–504PubMed Chandra B (1978) Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol 3:502–504PubMed

go back to reference Fodstad H, Forssell A, Liliequist B, Schannong M (1981) Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery 8:158–165PubMed Fodstad H, Forssell A, Liliequist B, Schannong M (1981) Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery 8:158–165PubMed

go back to reference Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE (2002) Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771–778PubMed Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE (2002) Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771–778PubMed

go back to reference Kaste M, Ramsay M (1979) Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke 10:519–522PubMed Kaste M, Ramsay M (1979) Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke 10:519–522PubMed

go back to reference Maurice-Williams RS (1978) Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J 1:945–947PubMedPubMedCentral Maurice-Williams RS (1978) Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J 1:945–947PubMedPubMedCentral

go back to reference Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, van de Vlekkert J, Bienfait HP, Boogaarts HD, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D, Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, Bienfait HP, Boogaarts HD, Klijn CJM, van Bilzen M, Dieks HJG, de Gans K, ten Holter JBM, de Kruijk JR, Leijzer CTJM, Molenaar D, van Oostenbrugge RJ, van Pamelen J, Spaander FHM, Vermeer SE, van de Vlekkert J, Voorend JM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D (2021) Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet 397:112–118PubMed Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, van de Vlekkert J, Bienfait HP, Boogaarts HD, Klijn CJM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D, Post R, Germans MR, Tjerkstra MA, Vergouwen MDI, Jellema K, Koot RW, Kruyt ND, Willems PWA, Wolfs JFC, de Beer FC, Kieft H, Nanda D, van der Pol B, Roks G, de Beer F, Halkes PHA, Reichman LJA, Brouwers PJAM, van den Berg-Vos RM, Kwa VIH, van der Ree TC, Bronner I, Bienfait HP, Boogaarts HD, Klijn CJM, van Bilzen M, Dieks HJG, de Gans K, ten Holter JBM, de Kruijk JR, Leijzer CTJM, Molenaar D, van Oostenbrugge RJ, van Pamelen J, Spaander FHM, Vermeer SE, van de Vlekkert J, Voorend JM, van den Berg R, Coert BA, Horn J, Majoie CBLM, Rinkel GJE, Roos YBWEM, Vandertop WP, Verbaan D (2021) Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet 397:112–118PubMed

go back to reference Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J (2000) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane database system reviews. John Wiley and Sons, Chichester, p CD001245 Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J (2000) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane database system reviews. John Wiley and Sons, Chichester, p CD001245

go back to reference Tsementzis SA, Hitchcock ER, Meyer CH (1990) Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien) 102:1–10 Tsementzis SA, Hitchcock ER, Meyer CH (1990) Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien) 102:1–10

go back to reference van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H (1977) Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann Neurol 2:238–242PubMed van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H (1977) Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann Neurol 2:238–242PubMed

go back to reference Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J (1984) Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:432–437PubMed Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J (1984) Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:432–437PubMed

go back to reference Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, Kleinig T, Spratt NJ, Thijs V, Wijeratne T, Cho DY, Shah D, Cloud GC, Phan T, Bladin C, Moey A, Aviv RI, Barras CD, Sharma G, Hsu CY, Ma H, Campbell BCV, Mitchell P, Yan B, Parsons MW, Tiainen M, Curtze S, Strbian D, Tang SC, Harvey J, Levi C, Donnan GA, Davis SM (2020) Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 19:980–987PubMed Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, Kleinig T, Spratt NJ, Thijs V, Wijeratne T, Cho DY, Shah D, Cloud GC, Phan T, Bladin C, Moey A, Aviv RI, Barras CD, Sharma G, Hsu CY, Ma H, Campbell BCV, Mitchell P, Yan B, Parsons MW, Tiainen M, Curtze S, Strbian D, Tang SC, Harvey J, Levi C, Donnan GA, Davis SM (2020) Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 19:980–987PubMed

go back to reference Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM (2014) Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis 23:1312–1318PubMed Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM (2014) Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis 23:1312–1318PubMed

go back to reference Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Krishnan K, Laska AC, Law ZK, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Seiffge D, Scutt P, Thanabalan J, Werring D, Whynes D, Bath PM, Investigators T (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet 391:2107–2115PubMedPubMedCentral Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Krishnan K, Laska AC, Law ZK, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Seiffge D, Scutt P, Thanabalan J, Werring D, Whynes D, Bath PM, Investigators T (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet 391:2107–2115PubMedPubMedCentral

go back to reference Collaborators H-IT (2020) Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 395:1927–1936 Collaborators H-IT (2020) Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 395:1927–1936

go back to reference Barer D, Ogilvie A, Henry D, Dronfield M, Coggon D, French S, Ellis S, Atkinson M, Langman M (1983) Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med 308:1571–1575PubMed Barer D, Ogilvie A, Henry D, Dronfield M, Coggon D, French S, Ellis S, Atkinson M, Langman M (1983) Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med 308:1571–1575PubMed

go back to reference Engqvist A, Brostrom O, von Feilitzen F, Halldin M, Nystrom B, Ost A, Reichard H, Sandqvist S, Torngren S, Wedlund JE (1979) Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. Scand J Gastroenterol 14:839–844PubMed Engqvist A, Brostrom O, von Feilitzen F, Halldin M, Nystrom B, Ost A, Reichard H, Sandqvist S, Torngren S, Wedlund JE (1979) Tranexamic acid in massive haemorrhage from the upper gastrointestinal tract: a double-blind study. Scand J Gastroenterol 14:839–844PubMed

go back to reference Tavakoli N, Mokhtare M, Agah S, Azizi A, Masoodi M, Amiri H, Sheikhvatan M, Syedsalehi B, Behnam B, Arabahmadi M, Mehrazi M (2018) Comparison of the efficacy of intravenous tranexamic acid with and without topical administration versus placebo in urgent endoscopy rate for acute gastrointestinal bleeding: a double-blind randomized controlled trial. United Eur Gastroenterol J 6:46–54 Tavakoli N, Mokhtare M, Agah S, Azizi A, Masoodi M, Amiri H, Sheikhvatan M, Syedsalehi B, Behnam B, Arabahmadi M, Mehrazi M (2018) Comparison of the efficacy of intravenous tranexamic acid with and without topical administration versus placebo in urgent endoscopy rate for acute gastrointestinal bleeding: a double-blind randomized controlled trial. United Eur Gastroenterol J 6:46–54

go back to reference von Holstein CC, Eriksson SB, Kallen R (1987) Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. Br Med J (Clin Res Ed) 294:7–10 von Holstein CC, Eriksson SB, Kallen R (1987) Tranexamic acid as an aid to reducing blood transfusion requirements in gastric and duodenal bleeding. Br Med J (Clin Res Ed) 294:7–10

go back to reference Cormack FCR, Jouhar AJ (1973) Tranexamic acid in upper gastrointestinal haemorrhage. Lancet 1:1207–1208PubMed Cormack FCR, Jouhar AJ (1973) Tranexamic acid in upper gastrointestinal haemorrhage. Lancet 1:1207–1208PubMed

go back to reference Bergqvist D, Dahlgren S, Hessman Y (1980) Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Upsala J Med Sci 85:173–178PubMed Bergqvist D, Dahlgren S, Hessman Y (1980) Local inhibition of the fibrinolytic system in patients with massive upper gastrointestinal hemorrhage. Upsala J Med Sci 85:173–178PubMed

go back to reference Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R (2018) Tranexamic acid for lower gi hemorrhage: a randomized placebo-controlled clinical trial. Dis Colon Rectum 61:99–106PubMed Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R (2018) Tranexamic acid for lower gi hemorrhage: a randomized placebo-controlled clinical trial. Dis Colon Rectum 61:99–106PubMed

go back to reference Saidi H, Ghavami S, Mirafzal A, Sisakht MT, Sotudehnia M (2017) Role of intra-gastric tranexamic acid in management of acute upper gastrointestinal bleeding. IIOAB J 8:76–81 Saidi H, Ghavami S, Mirafzal A, Sisakht MT, Sotudehnia M (2017) Role of intra-gastric tranexamic acid in management of acute upper gastrointestinal bleeding. IIOAB J 8:76–81

go back to reference Collaborators WT (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389:2105–2116 Collaborators WT (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389:2105–2116

go back to reference Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B, Susen S, Group ES (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15:R117PubMedPubMedCentral Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B, Susen S, Group ES (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15:R117PubMedPubMedCentral

go back to reference Myles PS, Smith JA, Painter T (2017) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376:1893PubMed Myles PS, Smith JA, Painter T (2017) Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376:1893PubMed